AMYRA Biotech Company
AMYRA Biotech is a company focused on developing therapeutic products for the treatment of celiac disease and gluten sensitivity. Their goal is to provide safe and effective treatments for these conditions by targeting gluten-immunogenic peptides, which are triggered by the ingestion of gluten in genetically predisposed individuals. These conditions are prevalent in the Western diet and pose significant public health concerns.
Headquarters:
Basel, Switzerland
Industry:
Biotechnology